LEUKOTRAP - CP2D- anticoagulant citrate phosphate double dextrose solution

Leukotrap - CP2D by

Drug Labeling and Warnings

Leukotrap - CP2D by is a Prescription medication manufactured, distributed, or labeled by Haemonetics Corporation, Haemonetics Manufacturing Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

HOW SUPPLIED

How Supplied: 250 mL CP2D Anticoagulant Solution is supplied in flexible PVC containers with a sterile, non-pyrogenic fluid path. 250 mL and 300 mL AS-3 Nutrient Solution is supplied in flexible PVC containers with a sterile, non-pyrogenic fluid path.

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

LEUKOTRAP - CP2D 
anticoagulant citrate phosphate double dextrose solution

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 53157-455
Route of Administration	INTRAVENOUS

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2) (DEXTROSE, UNSPECIFIED FORM - UNII:IY9XDZ35W2)	DEXTROSE, UNSPECIFIED FORM	4.64 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
SODIUM CITRATE (UNII: 1Q73Q2JULR)	2.63 g  in 100 mL
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)	0.327 g  in 100 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN)	0.222 g  in 100 mL
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 53157-455-02	250 mL in 1 BAG; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NDA	BN820915	10/09/2019

Labeler - Haemonetics Corporation (057827420)

Establishment
Name	Address	ID/FEI	Business Operations
Haemonetics Manufacturing Inc		078598396	manufacture(53157-455)